2017 Documentation Packaging 
Express Pharma
JUNE 5, 2024
The enduring harmful effects of these substances on human health are well-documented, leading to regulatory controls in numerous countries. The National Action Plan for Antimicrobial Resistance 2017 aims to limit antibiotics in industrial waste. Discharging antibiotics can promote antibiotic-resistant pathogens.
FDA Law Blog: Biosimilars
SEPTEMBER 27, 2023
Tobolowsky — Much has changed since the long-gone days of 2017. While the Nats being replaced by the Orioles as the dominant home team did not get a mention in the new Draft Guidance, there were plenty of other interesting changes made to the old 2017 draft guidance. By James E. Valentine & Mark A.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MARCH 30, 2023
The PD-1 inhibitor received an accelerated approval for this indication back in May 2017. There, the FDA suggested that the drugs undergo randomised controlled trials, which the document describes as the preferred approach, rather than single-arm trials.
RX Note
JUNE 5, 2023
The Hidden Truth Studies have shown that the antineoplastic residues can be found be on the external packaging of both oral and IV drugs. Change gloves every 30 minutes during compounding or immediately when damaged or contaminated, unless otherwise recommended by the manufacturer's documentation.
European Pharmaceutical Review
JANUARY 25, 2024
These standardised documents provide meticulously curated and scientifically approved information. 2017) “Danmark har flest smartphones i hele verden”, Berlingske, Eurostat (2022) “Medicine Use Statistics” European Commission. 11 This requirement directly contradicts what is included in Article 63. Article 63 EMA (29 January 2020).
pharmaphorum
JANUARY 18, 2022
Primary Packaging material designers. Secondary packagers. POST CONFERENCE WORKSHOP A: EU MDR 2017/745 Article 117 Requirements. Understand requirements to facilitate the documentation preparation needed to obtain a NB Opinion. View the full agenda and speaker line-up online: www.pfsamericas.com/. Smart device developers.
Pharma in Brief
JANUARY 9, 2022
The intent of the draft guidance document is to describe Health Canada’s expectations for manufacturers who distribute prescription drug information through an electronic means, such as a website or mobile app, that is directly linked to a product’s packaging or label. 2021 in the Courts. (a) a) PM(NOC) Regulations decisions.
Expert insights. Personalized for you.
98 
Let's personalize your content